Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BAXTER INTERNATIONAL INCBAX · Entity 1707 | SVP, President, APAC | March 01, 2023 | March 03, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BAXTER INTERNATIONAL INC
Report date March 01, 2023 · Filed March 03, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $1 par valueSEC Table I · non-derivative | Direct | 31,080 |
Ending reported balance
After 2023-03-01 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2023-03-01 · Grant · Acquired 6,171 · Balance 18,737 F1: The reporting person received a grant of restricted stock units which are scheduled to vest in three equal annual installments beginning on March 1, 2024, the first anniversary of the grant date, subject to satisfaction of the related vesting requirements set forth in the Baxter International Inc. 2021 Incentive Plan. Row 2 · 2023-03-01 · Grant · Acquired 12,343 · Balance 31,080 F2: The reporting person received a grant of restricted stock units which are scheduled to vest in three equal annual installments beginning on March 1, 2024, the first anniversary of the grant date, subject to satisfaction of the related vesting requirements set forth in the Baxter International Inc. 2021 Incentive Plan. The shares have terms and conditions which provide for vesting at termination if the reporting person is involuntarily terminated prior to the vesting date for other than cause. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $39.06 · Expires 2033-03-01 | Direct | 25,586 |
Reported balance
After 2023-03-01 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2023-03-01 · Grant · Acquired 25,586 · Balance 25,586 F3: The options become exercisable in three equal annual installments beginning on March 1, 2024, the first anniversary of the grant date. |
Filing footnotes · ownership attribution and instrument terms
F1: The reporting person received a grant of restricted stock units which are scheduled to vest in three equal annual installments beginning on March 1, 2024, the first anniversary of the grant date, subject to satisfaction of the related vesting requirements set forth in the Baxter International Inc. 2021 Incentive Plan.
F2: The reporting person received a grant of restricted stock units which are scheduled to vest in three equal annual installments beginning on March 1, 2024, the first anniversary of the grant date, subject to satisfaction of the related vesting requirements set forth in the Baxter International Inc. 2021 Incentive Plan. The shares have terms and conditions which provide for vesting at termination if the reporting person is involuntarily terminated prior to the vesting date for other than cause.
F3: The options become exercisable in three equal annual installments beginning on March 1, 2024, the first anniversary of the grant date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 01, 2023 Filed Mar 3, 2023 21:06 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | GrantStock Option (Right to Buy) · Derivative | 25,586 | $0.00 Strike: $39.06 | $0.00 |
DisclosureSEC source: 0001062993-23-005847 · form4.xml · derivative · entry 3 Flynn Steven · CIK 0001938766 · SVP, President, APAC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,586 Underlying: Common Stock, $1 par value · 25,586 shares Expires 2033-03-01 F3 · derivative.exercise_date: The options become exercisable in three equal annual installments beginning on March 1, 2024, the first anniversary of the grant date. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:06 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | GrantCommon Stock, $1 par value | 12,343 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-005847 · form4.xml · nonDerivative · entry 2 Flynn Steven · CIK 0001938766 · SVP, President, APAC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,080 F2 · shares: The reporting person received a grant of restricted stock units which are scheduled to vest in three equal annual installments beginning on March 1, 2024, the first anniversary of the grant date, subject to satisfaction of the related vesting requirements set forth in the Baxter International Inc. 2021 Incentive Plan. The shares have terms and conditions which provide for vesting at termination if the reporting person is involuntarily terminated prior to the vesting date for other than cause. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:06 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | GrantCommon Stock, $1 par value | 6,171 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-005847 · form4.xml · nonDerivative · entry 1 Flynn Steven · CIK 0001938766 · SVP, President, APAC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,737 F1 · shares: The reporting person received a grant of restricted stock units which are scheduled to vest in three equal annual installments beginning on March 1, 2024, the first anniversary of the grant date, subject to satisfaction of the related vesting requirements set forth in the Baxter International Inc. 2021 Incentive Plan. Read SEC document |
| February 13, 2023 Filed Feb 15, 2023 22:05 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | GrantCommon Stock, $1 par value | 516 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-003682 · form4.xml · nonDerivative · entry 1 Flynn Steven · CIK 0001938766 · SVP, President, APAC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,502 F1 · shares: Represents shares awarded from the performance share unit award granted on March 20, 2020 pursuant to the Equity Plan adopted by Baxter International Inc. (Baxter) as of such date (the 2020 PSUs). The award provided that one-third of the performance share units are awarded based on Baxter's Sales Compound Annual Growth Rate (Sales CAGR) performance, Baxter's Total Shareholder Return (TSR) performance, and Baxter's Total Return on Invested Capital (ROIC) performance over the three-year performance period January 1, 2020 to December 31, 2022 (the Three-Year Performance Period). These shares have vested as the Three-Year Performance Period has ended. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.